Evaluation of the prognostic value of IFN-γ release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Lienhardt, Christian ^a   Fielding, Katherine ^b   Hane, Abdoul A ^c   Niang, Aliou ^c   Ndao, Cheikh T ^a   Karam, Farba ^d   Fletcher, Helen ^e   Mbow, Fatou ^a   Gomis, Jules François ^a   Diadhiou, Roger ^d   Toupane, Maxime ^d   Dieye, Tandakha ^d   Mboup, Souleymane ^d  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Hospitalier Universitaire de Fann   (Senegal)

^d Centre Hospitalier Universitaire Aristide Le Dantec de Dakar   (Senegal)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME RELEASE; FEMALE; GENE REPLICATION; HOUSEHOLD; HUMAN; IMMUNE SYSTEM; INCIDENCE; LATENT PERIOD; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; SENEGAL; TUBERCULIN TEST; ADOLESCENT; CHILD; EVALUATION; FAMILY SIZE; FOLLOW UP; IMMUNOASSAY; METHODOLOGY; MULTIVARIATE ANALYSIS; PROGNOSIS; SECRETION; TIME;

BACILLI (CLASS); BACTERIA (MICROORGANISMS);

ADOLESCENT; ADULT; CHILD; FAMILY CHARACTERISTICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOASSAY; INCIDENCE; INTERFERON-GAMMA; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SENEGAL; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 77956272068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010508     Document Type: Article

References (32)

1. Huebner RE, Schein MF, Bass JB, Jr. (1993) The tuberculin skin test. Clin Infect Dis 17(6): 968-75.
2. Menzies RI (2000) Tuberculin skin testing. In: Reichman LB, Herschfield ES, eds. Tuberculosis: a comprehensive international approach, 2nd ed. New York: Marcel Dekker. pp 279-332.
3. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356(9235): 1099-104.
4. Pai M, Riley LW, Colford JM Jr. (2004) Interferon-gamma assays in the immuno-diagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761-76.
5. Menzies D, Pai M, Comstock G (2007) Meta-analysis: New tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research. Ann Intern Med 146: 340-354.
6. Mazurek GH, Jereb J, LoBue P, Iademarco MF, Metchock B, et al. (2005) Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54 (RR-15): 49-55.
7. NICE (2006) Clinical guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence, http://www.nice.org.uk/page.aspx?o=CG033NICEguideline. Accessed 2009 March 31.
8. Andersen P, Doherty TM, Pai M, Weldingh K (2007) The prognosis of latent tuberculosis: can disease be predicted? Trends Mol Med 13(5): 175-82.
9. Pai M, Zwerling A, Menzies D (2008) Systematic Review: T-Cell based Assays for the diagnosis of Latent Tuberculosis Infection: An Update. Ann Intern Med 149(3): 177-84.
10. Thiam S, Massi E, Ndir M, Diop AH, Ba F, et al. (2005) [Tuberculosis control in Senegal: update on care services and recommendations for improvement]. Med Trop 65(1): 43-8.
11. Lienhardt C, Bennett S, Del Prete G, Bah-Sow O, Newport M, et al. (2002) Investigation of environmental and host-related risk factors for tuberculosis in Africa. I. Methodological aspects of a combined design. Am J Epidemiol 155: 1066-1073.
12. Karam F, Mbow F, Fletcher H, Senghor CS, Coulibaly K, et al. (2008) Sensitivity of IFN-c Release Assay to detect Latent Tuberculosis Infection is retained in HIV-infected Patients but dependent on HIV/AIDS Progression. PLoS ONE 3(1): e1441.
13. Hill PC, Jackson-Sillah DJ, Fox A, Brookes RH, De Jong BC, et al. (2008) Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS ONE 3(1): e1379.
14. Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Deeks JJ, et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357(9273): 2017-21.
15. Lienhardt C (2001) From exposure to disease: the role of environmental factors in susceptibility to TB. Epidemiol Rev 23(1): 288-301.
16. http://www.who.int/tb/publications/global_report/2009/update/a-7_afr.pdf. Accessed 2010 March 26.
17. Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, et al. (2008) Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 149(11): 777-87.
18. Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A (2008) Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Respir Crit Care Med 177: 1164-1170.
19. Shafer RW, Edlin BR (1996) Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis 22(4): 683-704.
20. Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis. Expert Rev Mol Diagn 6(3): 413-422.
21. Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, et al. (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33: 956-973.
22. Franken WP, Arend SM, Thijsen SF, Bouwman JJ, Koster BF, et al. (2008) Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. Int J Tuberc Lung Dis 12(11): 1286-94.
23. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, et al. (2007) Longitudinal assessment of an ELIPOST Test for Mycobacterium tuberculosis Infection. PLoS Med 4(6): e192.
24. Vekemans J, Lienhardt C, Sillah JS, Wheeler JG, Lahai GP, et al. (2001) Tuberculosis contacts but not patients have higher c-interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun 69: 6554-7.
25. Doherty TM, Demissie A, Olobo J, Wolday D, Britton S, et al. (2002) Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 40(2): 704-6.
26. del Corral H, Paris SC, Marin ND, Marin DM, Lopez L, et al. (2009) IFNc Response to Mycobacterium tuberculosis, Risk of Infection and Disease in Household Contacts of Tuberculosis Patients in Colombia. PLoS ONE 4(12): e8257.
27. Mazurek GH, Weis SE, Moonan PK, Daley CL, Bernardo J, et al. (2007) Prospective Comparison of the Tuberculin Skin Test and 2 Whole-Blood Interferon-c Release Assays in Persons with Suspected Tuberculosis. Clin Infect Dis 45(7): 837-45.
28. Soysal A, Torun T, Efe S, Gencer H, Tahaoglu K, Bakir M (2008) Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection. Int J Tuberc Lung Dis 12: 50-6.
29. Weiss SE (2002) Contact investigations: how do they need to be designed for the 21st century? Am J Respir Crit Care Med 166(8): 1016-7.
30. World Health Organization (2008) Implementing the WHO Stop TB Strategy: A handbook for national tuberculosis programmes. World Health Organization., Geneva, Switzerland. 198 p.
31. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, et al. (2009) T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 13: 84-92.
32. Barry CE, 3rd, Boshoff HI, Dartois V, Dick T, Ehrt S, et al. (2009) The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 7(12): 845-55.